Your browser doesn't support javascript.
loading
Enfermedad por VIH, Inhibidores de integrasa y el futuro de los controladores elite, revisión bibliográfica / VIH disease, Integrase Strand Transfer Inhibitors and the future of elite controllers: bibliographic review
Lenis, William.
Affiliation
  • Lenis, William; Fundacion Clinica Valle Del Lili. Infectologia. Cali. CO
Infectio ; 23(supl.1): 61-72, dic. 2019. tab, graf
Article in Spanish | LILACS, COLNAL | ID: biblio-984510
Responsible library: CO359.1
RESUMEN
La Guía Colombiana de práctica clínica para la atención de la infección por VIH / Sida en adolescentes y adultos incluye como primera línea de tratamiento el uso de Inhibidores de integrasa; sin embargo, no incluye recomendaciones que soporten la decisión de tratar a los pacientes controladores elite (CE). La definición de controladores elite es confusa pues varía de un estudio a otro y se desconoce si las recomendaciones de tratamiento, se pueden aplicar a los controladores de forma similar; tampoco existen mecanismos apropiados para el seguimiento sistemático de los controladores elite cuando se inicia en ellos una terapia antirretroviral. Este artículo es una revisión bibliográfica de la información disponible sobre la definición de los pacientes controladores, y los controladores elite, su evolución clinica e inmunológica, el tratamiento y las terapias disponibles en Colombia.
ABSTRACT
The Colombian Guide to Clinical Practice for HIV / AIDS Care in Adolescents and Adults, includes as first line of treatment the use of integrase inhibitors; however, there is no information to support the decision to treat elite control patients (EC). The definition of elite controller is confusing, because of the changes in definitions between studies, and it is unknown whether these recommendations apply to these patients in a similar way; and how should be systematic follow-up of elite controllers when antiretroviral therapy is initiated. Present paper is a bibliographic review of the available information on the definition of the controllers, and elite controllers its clinical and immunological evolution, the treatment and therapies available in Colombia.
Subject(s)


Full text: Available Collection: International databases Health context: Sustainable Health Agenda for the Americas / SDG3 - Health and Well-Being Health problem: Goal 9: Noncommunicable diseases and mental health / Target 3.3: End transmission of communicable diseases Database: COLNAL / LILACS Main subject: Acquired Immunodeficiency Syndrome / HIV / Practice Guideline / Integrase Inhibitors Type of study: Practice guideline / Prognostic study Limits: Adult / Female / Humans / Male Language: Spanish Journal: Infectio Journal subject: Communicable Diseases Year: 2019 Document type: Article Affiliation country: Colombia Institution/Affiliation country: Fundacion Clinica Valle Del Lili/CO

Full text: Available Collection: International databases Health context: Sustainable Health Agenda for the Americas / SDG3 - Health and Well-Being Health problem: Goal 9: Noncommunicable diseases and mental health / Target 3.3: End transmission of communicable diseases Database: COLNAL / LILACS Main subject: Acquired Immunodeficiency Syndrome / HIV / Practice Guideline / Integrase Inhibitors Type of study: Practice guideline / Prognostic study Limits: Adult / Female / Humans / Male Language: Spanish Journal: Infectio Journal subject: Communicable Diseases Year: 2019 Document type: Article Affiliation country: Colombia Institution/Affiliation country: Fundacion Clinica Valle Del Lili/CO
...